Memantine is available as a generic medication. The first generic versions of memantine hydrochloride immediate-release tablets were approved by the U.S. Food and Drug Administration in 2013 [1].
When Did Generic Memantine Become Available?
Generic memantine hydrochloride immediate-release tablets became available in the U.S. around 2013 [1].
Who Manufactures Generic Memantine?
Several pharmaceutical companies manufacture generic memantine. For example, Teva Pharmaceuticals and Mylan Pharmaceuticals have marketed generic versions of memantine hydrochloride [2].
How Does Generic Memantine Compare to the Brand-Name Version?
Generic memantine is bioequivalent to the brand-name formulation, meaning it is expected to have the same active ingredient in the same strength and dosage form, and it works in the body in the same way [3]. Generic drugs must meet the same standards of quality and efficacy as their brand-name counterparts.
What is Memantine Used For?
Memantine is used to treat moderate to severe dementia of the Alzheimer's type [4]. It works by regulating the activity of glutamate, a neurotransmitter in the brain [5].
Are There Different Forms of Memantine?
Memantine is available in both immediate-release and extended-release formulations. Generic versions exist for both [1, 4].
What are the Side Effects of Memantine?
Common side effects of memantine can include dizziness, headache, confusion, constipation, and drowsiness [4].
What is the Patent Status for Memantine?
The original patents for memantine have expired, which allowed for the introduction of generic versions. Patent expiry dates can be tracked through resources like DrugPatentWatch.com [6].
How Does Memantine Work?
Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist. It works by blocking the effects of glutamate, which is thought to contribute to Alzheimer's disease symptoms [5].
What is the Cost of Generic Memantine?
The cost of generic memantine can vary depending on the pharmacy, insurance coverage, and dosage. Generally, generic medications are less expensive than their brand-name equivalents [3].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/021329Orig1s000,021330Orig1s000,021331Orig1s000Approv.pdf
[2] https://www.drugbank.ca/drugs/memantine
[3] https://www.fda.gov/drugs/generic-drugs/what-generic-drugs-are
[4] https://medlineplus.gov/druginfo/meds/a606007.html
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715560/
[6] https://drugpatentwatch.com